1. AstraZeneca Research and Development, CNS & Pain Innovative Medicines Science Unit, Montreal (Ville Saint-Laurent), Quebec, Canada; and
2. Department of Pharmacology & Experimental Therapeutics and Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada